There is general agreement among all who have used Ca45 for kinetic studies in either man or experimental animals that the decrease with time of specific activity of serum calcium can be expressed mathematically by a series of exponential terms. Beyond this, however, opinions diverge, and there is no agreement on either the number of exponential terms needed, the scheme of the body's calcium economy, or the analytical approach for solving the scheme. This paper aims at presenting a general scheme of calcium metabolism, its resolution by a combination of balance and isotope technics, and a critical review of past work.
DEFINITIONS AND NOTATION
General definitions and notation, those that apply to kinetic analysis generally, regardless of whether and how Ca metabolism is analyzed, are as follows: The pool, P, is the sum of two or more compartments, M, in units of mass, between which various exchange processes occur. Exchange is the bidirectional movement of ions between two compartments of a pool without detectable change in compartment size. Isoexchange is the movement of ions of the same element, e.g., Ca45 4=k Ca4O; heteroexchange is that of different elements. This paper will consider only isoionic exchange. Unidirectional entries to and losses from a pool are detectable movements into or out of a pool that may or may not result in a change of pool size. If the amount that enters equals the amount that leaves, pool size does not change, and the pool is in dynamic equilibrium. V designates the rate in units of mass per unit time of an exchange process, and v, that of a unidirectional process.
R indicates radioactivity measurements, in counts per minute, or per cent dose; R. indicates specific radioactivity (SA), in counts per minute per milligram Ca, or per cent dose per milligram Ca.
Definitions and notations specific to the scheme of Ca metabolism shown in Figure 1 follow. The system under analysis is a central Ca pool, the skeleton and the intestine, in skeleton, v_= Ca removed from skeleton, and VT= total Ca loss from P. Exchanges within P among M, Ml, M2, and Mk1, occur at rates V1, V2, and V3. Further notation is: RIB, R.., RID, and RpF = SA of serum, urinary, digestive-juice, and fecal Ca, respectively, at time t; R., RD, RF, and R, = radioactivity present in urine, digestive juices, feces, and bone, respectively, at time t; Rf = radioactivity due to endogenous fecal Ca; Ri = radioactivity injected at t = 0; and Ring = radioactivity ingested at t = 0. DISCUSSION I. Schemes of Ca metabolism Figure 1 represents two possible schemes of Ca metabolism. They are alike in that the system under analysis consists of a central Ca pool, skeleton, intestine, and loss of Ca via urine.
They differ in their account of the origin of fecal endogenous Ca. Scheme I pictures fecal endogenous Ca as secreted into the bowel and not subject to intestinal absorption. This is the simplest way to account for endogenous Ca in the stool. Scheme II takes more explicit account of what is known of the formation of Ca-containing digestive juices. It derives endogenous fecal Ca from secretions into the bowel, assuming that the fraction of digestive-juice Ca absorbed is the same as that absorbed from food. Authors have used either scheme, often without specifying which. Few have studied the entire system; most have studied either absorption or bone metabolism, for example, but not both.
In human studies, Blau and his associates (1) used scheme II In animal studies, Visek, Monroe, Swanson, Comar, and Hansard (10, 11) have calculated vf and v. in the cow, using a scheme like I. Aubert and Milhaud (3) have also used scheme I for their rat studies; as in their human studies, they solved for all parameters. Bauer and coworkers, by defining "exchangeable space" and bone "accretion," have in fact proposed a method for measuring P, vo+, and vo_ in the rat, both in individual bones (12) and in the whole animal (13) . For the latter, they had to calculate the loss of Ca in the excreta, but did not distinguish urinary from fecal endogenous loss.
Of the relationships inherent in the schemes, some are common to both. By definition, As = Vi -(V. + VF)
[1] (A8 here is identical with traditional Ca balance).
If P is in dynamic equilibrium, then ZVout p = Vin P; [2] in other words, Ap must always equal 0. [5] Absorption can also be determined by Va = Vi -VF +Vf, [6] and the fraction absorbed is a = va/vi. [7] In scheme II, some Ca that leaves via Vd returns to it via va, but diluted with vi. In other words, VF contains some unabsorbed Vd and vi. The unabsorbed Vd is equivalent to v1 in scheme I. Hence Vf = Vd (I -a).
[8]
Equation 4 again applies. Equation 5 applies as well, but absorption is also defined by Va = Vi + Vd -VF, [9] and the fraction absorbed becomes a = Va/ (Vi + Vd). [10] Equations 8, 9, and 10 are based on the assumption that vi and Vd are absorbed to the same extent and therefore presumably are thoroughly mixed (1) . (Figure 1) , it is assumed that during the experimental period either v0, is completely unlabeled, or that a constant fraction of the radioactivity deposited via v,+ is returned to P. This second possibility has been considered explicitly by Heaney and Whedon (2) . Most authors, however, believe that Ca returned to P by bone resorption is unlabeled. In scheme II, some of the radioactivity lost from the pool via Vd is returned to it via Va. In order for the SA of P to decrease exponentially under these conditions, it must be assumed that vi and Vd undergo rapid mixing and homogenization before absorption, and that the rate of absorption throughout the experiment is relatively constant. 3) Homogenization within each compartment is assumed to be instantaneous. This is not true in fact, but the rate of homogenization is generally very much greater than the rates of exchange between two compartments.
II. Resolution of system
The system is resolved by a combination of isotope and balance measurements. In most studies, Car2 has been administered as a single dose either intravenously or by mouth. Although the over-all approach is similar in either case, some assumptions, methods, and the validity of certain of the experimental findings differ. Therefore, it will be useful to discuss both cases separately.
A. Intravenous administration. In human studies, the time-course of R.B is best described by an equation of the type,
which holds for 6 to 7 days after injection of Car (3, 14, 16) . Similar, but three-term equations have been proposed by Krane and associates (7) and Bauer and associates (8) . The disappear-2 Isotope measurements will be designated by Cat.
ance of injected Sr from the blood has also been described by a four-term equation (17) . The first three terms of Equation 11 become negligible within the first 48 hours. Thereafter, the timecourse of RSB is described by R8B = A4e-a4t. [12] If f(t) is the time-course of R.B and if all unidirectional losses from P are assumed to be from plasma, then at any time after injected Car has become distributed homogeneously in plasma Ca, a period shown to be less than 1 minute (3), one can write for scheme I:
[13a]
[13b]
[13c] Upon integration between limits, these equations become,
If follows that RU]tt2/vu = RF]tlt2/vf = RO+]tIt2/vo+. [15] Moreover, at any time t, R,]0t + RF]ot + R,+]ot + Mf(t) + M1g(t) + M2h(t) + M3i(t) = Ri, [16] where M = mass of Ca in serum, M1, M2, and M3 are amounts of Ca in the other compartments of P, and f(t), g(t), h(t), and i(t) are the functions with time of SA of Ca in the various compartments. The same equations apply to Scheme II if vf is replaced by vd (1 -a).
Two simplified methods have been proposed on the assumption that R.B is a simple monoex-
, that what happens during the first 36 hours after injection can be neglected. The first, that of Bauer and collaborators (8) , is based on experiments with rats (12, 13) , and has been used in human studies by them and other workers (5, 6, 8, 16, 18) .
With it, vf, v0+, and P can be determined. The method is based on the following relationship, derived from Equation 16:
RX Pf(t) + (v,+ + vu + Vf) f(t)dt. [17] This states that at any given moment, total Ri equals the sum of radioactivity remaining in P plus R?, R., and RF. f(t) is set equal to the timecourse of SA. Equation 17 divided by P gives
Equation 18:
Iff(t) is a single-term exponential expression and if no labeled Ca has returned to the pool between times 0 and t, (v0+ + vu + vf)/P equals a4 in Equation 12 , which is determined experimentally. Equation 18 can then be solved for P: rt
. [19] By measuring the area under the curve described by f(t)dt and the slope a4 on semilog coordi- RIB = (Rj/P)e-(1T/P) t [20] Extrapolating this to t = 0 gives R8Bo = Ri/P, [21] hence P can be calculated. R.B = Aiekt + A2e k2t + A3e-kt. [22] They assume that each exponential term describes the behavior of Ca in a different compartment, and express A 1, A2, and A3 as the percentage of the dose of Ca45 per gram Ca. They then define the size of each compartment, Q1, Q2, and Q3, as:
Krane and co-workers (7) (3) . This type of analysis requires a well-defined model of compartments and rates, and the model shown in Figure 2 was chosen; it represents a mammillary system with the blood as the central compartment. The system is resolved as follows. Let Ri = the amount of Car injected at t = 0, and R, R1, R2, and R3 = the amount of Car in the blood, and in compartments 1, 2, and 3, respectively, at time t. Also, let dR, dR1, dR2, and dR3 represent the change in the amount of Car per time dt. The dynamic state of the system can then be expressed by the following equations:
Knowing M, the total blood Ca content, one can then calculate all other unknowns and thereby resolve the system. Besides the assumptions discussed above (see Discussion, I), this analysis also assumes that all unidirectional losses from P (v., VF, and v0+) occur by way of the central compartment. It seems reasonable to equate v0+, the unidirectional loss of Ca from P into bone, with bone formation. As long, however, as a formal distinction is maintained between bidirectional Ca exchange and unidirectional Ca movement from pool to bonei.e., bone formation and its component processes -the analysis described here and by schemes I and I I (Figure 1) (Figure 3) , each resolved differently and leading to different results. One or more additional exchanges may occur, so that the model includes one or several cycles. Under those conditions, the model can no longer be solved. Unidirectional entries and losses may also occur via a compartment other than the central one. Although resolution of such models is feasible, it becomes more complex.
Aubert and Milhaud (3) have advanced arguments in favor of model 1 (Figure 3 Figure 3) , the model chosen affects only the manner in which the Ca of P (M + M1 + M2 + M3) is partitioned among the three other compartments (with the blood Ca constant), but has almost no effect on the values calculated for VT and its component rates. When experimental results from a normal person, a patient with Paget's disease, and one with hypothyroidism were calculated according to scheme I (Figure 1) , it was shown (3) that rates and compartment sizes varied considerably, but that the rate constants (rate/mass) varied less, indicating that the same exchange process was measured in all three cases. Aubert and Milhaud (3) postulate that M1 is the Ca of the extracellular fluid, M2 iS the more labile portion of the tissue Ca, and M3 is the less labile tissue Ca plus the exchangeable Ca of bone.
The relative error that arises in the simplified as compared to the general method can be estimated by neglecting the first three terms of Equation 11 [see (3) This method is theoretically sound, and is independent of the type of function that RB may have, since the Ca 4 content of the bone is measured directly. The method cannot, however, be extended to measure all the parameters of scheme I or II in accordance with Equation 18 , since in rats the time-course of RSB cannot be correctly represented by a monoexponential function (3, 20) .
Other authors (3, 23, 24) have applied the general method of resolution described for studies with humans to studies with rats. Hence all parameters of either scheme I or II can be calculated without killing a large number of animals. According to Milhaud, Remagen, Gomes de Matos, and Aubert (23) , RB in rats between 0 and 72 hours after injection can be described adequately by a two-term exponential equation of the type, RIB = Aie-alt + A2ea2t, [27] shown experimentally that the calculated values for vt+ agree well with experimental values obtained by analysis of the whole skeleton. Bronner (20) used a model of Ca metabolism like that shown in Figure 2 . He compared Ca uptake of the skeleton with that in certain tissues and organs. By calculating constants and fitting them to equations similar to Equations 25a, b, and c, he was able to show that the model adequately represented the experimental data. He did not, however, resolve the constants into absolute rates and compartment sizes.
B. Oral administration. Several authors have attempted to measure Ca absorption in man (1, 5, 15, 25) or animals (10, 11) by giving Car orally. At first glance, this seems the simplest and most direct approach to measuring absorption, but it involves major difficulties of interpretation and technique. If a = fraction of Ca that is absorbed, then the radioactivity absorbed, R., is given by Ra = aRing. [28] Obviously, the metabolic processes affecting Ca are identical for exogenous and endogenous Ca. Therefore, the physiological behavior of absorbed Ca can be analyzed as though Ca were injected intravenously. Then, if a can be determined, the system can be solved.
In one method of determining absorption, no intravenous experiment precedes the oral experiment. Analysis of this case according to scheme I follows. Equation 6 If RF of Car is recorded for more than 5 to 7 days, unabsorbed Car will have been excreted in the stool; Car then excreted in the stool is endogenous, and analysis of this latter part of the curve can proceed as for iv injection.
In a second method for determining absorption, the oral experiment can be compared with an intravenous one. If an iv experiment is performed shortly before or after the absorption study, data of both studies can be combined to calculate a, on the assumption that no significant metabolic change has occurred between the two studies. Two methods of calculating absorption in this way have been proposed. Both are based on Equation 28 and are independent of the scheme (I or II) used. First, the urine method [method B in (26) am = ar(P/P').
[40]
In the urine method, am = a, if P = P' and VT = VT'. The value of e(DTIP)t in Equation 39 is small, however, when t = 6 days. Hence the relationship between am and a, is determined essentially by VT/VT'. In the pool method, on the other hand, the relationship between am and a, is determined only by P/P' and is completely independent of the rates of turnover of the pool. Nevertheless, if VT/P remains constant in the two experiments, as measurement of R8,, can easily verify, the urine method is better than the pool method, since it is independent of the type of function (monoexponential or not) that may represent the time-course of R,,. Moreover, when P is determined by the simplified method, the error can be fairly large (see above).
General resolution of the system is possible and all parameters (by either scheme I or II) can theoretically be solved for in an oral experiment. If a tracer dose of Car is added to a test meal, general resolution of the system is possible by the radioactivity balance method, even if comparison with an iv experiment is not feasible. It is necessary to subject the patient to the usual balance study to determine v., VF, vi When comparison with an iv experiment is possible, combination of either the pool or the urine method with a Ca balance study gives a, P. VT, V, vi, and A. In scheme I, v., V_, vo+, and Vf are given by Equations 7, 5, 3, and 4, respectively. In scheme II, combination of Equations 9 and 10 gives Vd and Va; vf, v,+ and vt_ are given by Equations 8, 4, and 3, respectively.
In the case of Ca absorption of a Car-labeled compound, a Ca balance has no meaning unless all dietary Ca is in the form of the labeled compound. This can be done in animal, but not easily in human studies. For resolution of the system, data from an iv study must be used. Since, however, a calculated for the labeled compound need bear no relation to a of the food in general, resolution of the system may not be meaningful.
On the other hand, if absorption of a specific Ca compound is to be compared with that of dietary Ca in general, experiments (by both injection and ingestion can be performed simultaneously with two different isotopes of Ca, e.g., Ca45 and Ca47 (26) . The a of the Ca compound can then be calculated by either urine or pool method.
Oral studies have both theoretical and physiological limitations. To resolve all parameters of either scheme I or II after oral administration of Car, one must assume that aRing behaves like an equivalent amount of Ri. Absorption is not an instantaneous process; rather, it takes 2 to 3 hours before R8B reaches its peak after an oral dose (27) . The error becomes even larger with the simplified method, which presupposes instantaneous homogenization of the entire pool. Sufficiently frequent blood sampling after ingestion of tracer, however, could establish an equation of the type: RSB =-(A1 + A2 + A3 + A4)e-aIt + Ale -at + As2e-a2t + A 3e-a~t + A 4e-a4t. [43] From this, the system could be resolved, since Equation 43 takes into account the time of absorption.
There are also physiological considerations. To use an oral study for the resolution of the system, one must assume all dietary Ca to be labeled homogeneously before the study. Since this is impractical, Car is usually added to milk (27) or to a particular Ca compound, like a Ca salt (28) . Absorption of milk Ca must be assumed not to differ from that of the general dietary Ca, an assumption that remains unproved. In the second case, one can measure Ca absorption of the salt in question, but cannot, as shown above, resolve the entire system. Oral experiments, therefore, do not appear to be suitable for study of Ca metabolism in general. The absorbability of Ca in specific foods or compounds can be readily determined in conjunction with an iv study.
III. Long-term behavior of RSB.
All the human studies discussed so far involve periods of 6 to 8 days after isotope administration. Then the monoexponential decrease of RSB observed between 2 and 6 to 7 days ceases, and the curve assumes a new slope. Two interpretations of this phenomenon have been offered.
Heaney and Whedon (2) believe the new and flatter slope of the R8B curve, seen about 1 week after injection of radioactivity, is due to the return of label into P, resulting from resorption of labeled bone after a period 0. Dansky and Heaney [quoted in (2) ] have derived a mathematical expression that accounts for recycling in an open single-compartment system:
where xo = the specific radioactivity at t = 0, K = the rate constant of loss from the pool, kb' = the rate constant of loss from bone, and 0 = time interval required for recycling the tracer. Heaney and Whedon (2) have applied Equation 44 at the end of the second cycle-i.e., for 20 and when n = 1-in order to calculate the fraction of vt+ that returns to P under these conditions. This fraction was found to vary between 20 and 40%, with a mean of 32%. 893 Aubert and Milhaud (3) attribute the same break observed in the ROB curve to a slow, physicochemical phenomenon. They propose to solve for it by adding a fifth compartment, M4, to the four-compartment mammillary exchange system shown in Figure 2 . According to their calculations, the true vo+ is about 25% smaller than that calculated by the general methods discussed above.
Although both Heaney and Whedon, and Aubert and Milhaud arrive at similar estimates of the magnitude of this slow phenomenon, they differ profoundly in interpretation. Heaney and Whedon consider it to be due to bone resorption; Aubert and Milhaud [also Krane and associates (7)] attribute it to a slow exchange. Only further studies can resolve this point, especially in the light of the "slow exchange process" described by Marshall, Rowland, and Jowsey (29) in vivo and by Neuman and Neuman (30) in vitro. The process described by Marshall and associates, however, is more akin to a translocation of Ca in the skeleton without measurable effect on P and is in no way comparable to exchange as defined here.
IV. Special methods of system analysis
In Car infusion studies, Rich, Ensinck, and Fellows (31, 32) have attempted to correlate estimated changes in pool size with clinical states. Rich (31) administered a mixture of Ca gluconate and Ca glycerophosphate labeled with Car at a constant rate (110 mg Ca per hour) for 4 hours, and measured radioactivity in serum and excreta. P and v0w were calculated by the method of Bauer and associates (8) . The size of the rapidly exchanging Ca P was calculated by use of the curve representing increase in R8B during infusion. Rich defined this P at time t by the relationship: ER = total radioactivity injected by time t/serum SA at time t (Equation 45). In later studies (32) , high-specific-activity Ca45 in isotonic saline was infused by a constant-rate pump, and the "miscible calcium" was defined as the rate at which Ca45 was administered divided by the slope of the regression curve fitted to the rising specific-activity values measured during the experiment. In these studies, only "miscible Ca" was determined.
To use the method of Bauer and associates (8) for calculating P and vo+, it is essential to define a zero time. This cannot be done precisely in Rich's method, and his later studies (32) abandon this approach. ER, as defined by Equation 45, is not only a function of the size of exchangeable P, but equally a function of all the rates. Whatever scheme is chosen to resolve the system, if two subjects have the same size pool, but different rates of exchange, the serum Ca will undergo exchange with different quantities of Ca during the infusion. Consequently, ER will differ in the two cases, even though the pools are in fact identical. This argument applies also to the rates of irreversible loss and gain of the central compartment, but over a 4-hour period, these are small in comparison to the rates of exchange.
There is also no way of predicting at present the effect of the Ca infusion (110 mg Ca per hour) on the parameters of the system, even if serum Ca concentration is unchanged. In the later studies, however, the total Ca infused was negligible (_< 30 lug Ca).
Despite these criticisms of the theoretical significance of the ER, it is interesting to note that the rate constants V1/M1, V2/M2, V3/M3 are relatively invariant (3). Hence, a major change in M is likely to be accompanied by a comparable change in V. This may explain why Rich was able to distinguish by this test major alterations in ER associated with certain diseases.
In another analysis, Krane and associates (7) define the Ca pool of man at time t as: Pt = body retention of radioactivity at time t/serum SA at time t (Equation 46). As defined, this "pool" must necessarily be a function of time. Krane and associates, however, claim that Pt approaches a limit at t = 9 days, thus permitting a comparison of Pt (9 days) in different patients. They state: "The concept of a calcium 'pool' makes no assumption based on the shape of the curves, but reflects the fact that a lower specific activity at any time means a larger mass of dilution." (7) . In other words, the "pool at time t" becomes a rather complex function of P and of v0+ and VT.
Moreover, Pt increases indefinitely with time. The notion of a "pool at time t" does not add to what can be learned by solving the system. The excretion index defined by Bronner and associates (33, 34) consists of three parameters after iv injection of Car where t = days:
[50] C = A/B.
Rewritten in terms of Equation 14a
:
[51] r6
The integral in Equation 51 is independent of the nature (mono-or multiexponential) of the SA curve. Values of A, B, C can be obtained simply by measuring SA, Ca concentration, and the volume of 6 successive 24-hour urine samples after iv injection of tracer. The way these parameters vary indicates variations of Vu and VT. Since Vo+ is the major component of VT, variation in the excretion index suggests how vu and also v,+ are affected. Although the excretion index does not give a complete description of Ca metabolism, it can be useful in clinical screening studies, e.g., to evaluate the effect of drugs.
In a recent preliminary publication, Bhandarkar, Bluhm, MacGregor, and Nordin (35) propose to measure Ca absorption by giving patients labeled CaCl2 and measuring RSB after 2 hours. To support the claim that RaB is a measure of absorption, these workers plotted RB against "net calcium absorption," (Vi -VF), and observed a linear relation with an error of approximately i 42%. Clearly, such a test provides only an indication, not a true measure, of absorption; it may be useful in certain screening studies.
CONCLUSION
The preceding discussion has shown that a number of conditions must be met to obtain meaningful answers in a kinetic analysis of Ca metabolism. a) There are experimental conditions for isotope administration. To study a system in a steady state, the tracer introduced must perturb it as little as possible. Since the blood represents a well-defined compartment, highspecific-activity Car is best administered by rapid, iv injection. In other words, the mass of Car introduced must be negligibly small in relation to that of the blood.
b) The disappearance curve must be established. The precision of measurement of this fundamental parameter is a function of the number of measurements made, particularly during the early part of the curve, when it falls off rapidly. When the general method of resolution is used in human studies, blood samples should be obtained at 2, 4, 8, 15, 30, 45 , 60, 75, 120, 180, 360, 540, and 720 minutes, and 24 and 48 hours after injection. The rest of the curve is more easily obtained by measuring R8U. The size of the blood Ca compartment is determined from plasma volume. The simplified method may be used when the patient is a small child, or when many patients are being studied for comparative purposes and their pools are known to be small. Then, all determinations may be of R8U. c) To measure Ca intake and output, the diet must be weighed and its Ca content determined. Measurement of urinary Ca and Car output presents no difficulties. The principal problem with fecal Ca output is to establish the correct time correspondence between intake and output, in terms of both balance and kinetic measurements. Since P becomes homogenized between 36 and 48 hours after injection, the simplest method is to give a suitable marker, e.g., 1 g carmine, at 36 hours, e.g., at the evening meal of day 2, and to collect all stools separately thereafter. Six days later, another marker is given. Total Ca and Car is then measured in all stools for that period, i.e., from the stool with 895 the first trace of the first marker through, but excluding, the stool with the first trace of the second marker.
For analysis of results, the general method of resolution best minimizes all sources of error (see Discussion, II). Choice of model ( Figure  3) will affect primarily the determination of M and V within P, and only slightly that of unidirectional processes. Consequently, an investigator may treat data according to more than one model; if this is done systematically, it may indicate an ultimate choice of model. At present, experimental evidence does not permit a clearcut choice between schemes I and II ( Figure  1 ), but as data accumulate, one scheme or the other will be preferred for consistent interpretation. Again, data -may be treated according to both schemes.
Although the simplified method leads to erroneously high values for P and v.+, it can be used in comparative series where the true P is small, and where greater simplicity of analysis and calculation becomes important. The simplified method also has a place as a diagnostic tool in a metabolic ward, provided its limitations are taken into account. In absorption studies, oral administration of Car is theoretically valid only to measure Ca absorption for a given Ca compound, or a single, (uniformly labeled) Ca-containing food. For this, data from an iv study must be available. Under these conditions, a is best calculated by the urine method (Equation 37). In screening studies on the effect of a drug on Ca metabolism, evaluation of the excretion index islthe most economical method (see Discussion, IV).
SUMMARY
A detailed, formal analysis of Ca metabolism has been presented that permits measurement of sizes and exchange rates of compartments constituting the Ca pool, as well as the following unidirectional rates: bone formation and resorption, absorption, urinary Ca output, and endogenous fecal Ca loss. The last can also be expressed as a fraction of the rate of formation of digestive juice Ca.
Two possible schemes of Ca metabolism have been presented and analyzed; these differ in their account of the origin of endogenous fecal Ca.
Calculations according to either scheme are detailed.
Both general and special methods of analysis of Ca metabolism have been presented, their advantages and drawbacks discussed, and their applicability evaluated.
